Cardio Diagnostics Holdings Inc (CDIO) is now in the Fair zone, suggesting that its current forward PS ratio of 9.88 is considered Fairly compared with the five-year average of -3.95. The fair price of Cardio Diagnostics Holdings Inc (CDIO) is between 2.84 to 14.66 according to relative valuation method.

Relative Value

Fair Zone

2.84-14.66

Current Price：5.06

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Cardio Diagnostics Holdings Inc (CDIO) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Cardio Diagnostics Holdings Inc (CDIO) has a current Price-to-Book (P/B) ratio of 0.62. Compared to its 3-year average P/B ratio of 4.44, the current P/B ratio is approximately -86.14% higher. Relative to its 5-year average P/B ratio of 4.73, the current P/B ratio is about -86.99% higher. Cardio Diagnostics Holdings Inc (CDIO) has a Forward Free Cash Flow (FCF) yield of approximately -114.70%. Compared to its 3-year average FCF yield of -59.35%, the current FCF yield is approximately 93.26% lower. Relative to its 5-year average FCF yield of -55.75%, the current FCF yield is about 105.72% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for CDIO competitors is 4.42, providing a benchmark for relative valuation. Cardio Diagnostics Holdings Inc Corp (CDIO.O) exhibits a P/S ratio of 9.88, which is 123.68% above the industry average. Given its robust revenue growth of -56.61%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of CDIO increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of CDIO in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is CDIO currently overvalued or undervalued?

What is Cardio Diagnostics Holdings Inc (CDIO) fair value?

CDIO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Cardio Diagnostics Holdings Inc (CDIO) is between 2.84 to 14.66 according to relative valuation method.

How does CDIO's valuation metrics compare to the industry average?

The average P/S ratio for CDIO's competitors is 4.42, providing a benchmark for relative valuation. Cardio Diagnostics Holdings Inc Corp (CDIO) exhibits a P/S ratio of 9.88, which is 123.68% above the industry average. Given its robust revenue growth of -56.61%, this premium appears unsustainable.

What is the current P/B ratio for Cardio Diagnostics Holdings Inc (CDIO) as of Mar 02 2026?

As of Mar 02 2026, Cardio Diagnostics Holdings Inc (CDIO) has a P/B ratio of 0.62. This indicates that the market values CDIO at 0.62 times its book value.

What is the current FCF Yield for Cardio Diagnostics Holdings Inc (CDIO) as of Mar 02 2026?

As of Mar 02 2026, Cardio Diagnostics Holdings Inc (CDIO) has a FCF Yield of -114.70%. This means that for every dollar of Cardio Diagnostics Holdings Inc's market capitalization, the company generates -114.70 cents in free cash flow.

What is the current Forward P/E ratio for Cardio Diagnostics Holdings Inc (CDIO) as of Mar 02 2026?

As of Mar 02 2026, Cardio Diagnostics Holdings Inc (CDIO) has a Forward P/E ratio of -0.41. This means the market is willing to pay $-0.41 for every dollar of Cardio Diagnostics Holdings Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Cardio Diagnostics Holdings Inc (CDIO) as of Mar 02 2026?

As of Mar 02 2026, Cardio Diagnostics Holdings Inc (CDIO) has a Forward P/S ratio of 9.88. This means the market is valuing CDIO at $9.88 for every dollar of expected revenue over the next 12 months.

CDIO Valuation